# A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

> **NCT07738614** · PHASE1 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 56 (estimated)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** Eloralintide
- **DRUG:** Placebo
- **DRUG:** Acetaminophen

## Key facts

- **NCT ID:** NCT07738614
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-31
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07738614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07738614, "A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07738614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*